Current diagnosis and treatment of temporal arteritis

Current Treatment Options in Cardiovascular Medicine

Volumn 8, Issue 2, 2006, Pages 145-151

  Schmidt, Wolfgang A ^a  

^a Medical Center for Rheumatology Berlin Buch   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIUM; CORTICOSTEROID DERIVATIVE; GLUCOCORTICOID; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PREDNISOLONE; PROTON PUMP INHIBITOR; RISEDRONIC ACID; RITUXIMAB; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VITAMIN D; WARFARIN;

ANKYLOSING SPONDYLITIS; ARTERIOGRAPHY; AUSCULTATION; AXILLARY ARTERY; BEHAVIOR MODIFICATION; BLEEDING DISORDER; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT DISORDER; BONE MARROW SUPPRESSION; CARDIOVASCULAR DISEASE; CATARACT; CLINICAL ASSESSMENT; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DRUG COST; DRUG DOSE REDUCTION; DRUG INFUSION; DYSPEPSIA; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGITIS; EYE DISEASE; GIANT CELL ARTERITIS; GLAUCOMA; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOPHOSPHATEMIA; IMAGING SYSTEM; INFECTION; INSOMNIA; INTRAOCULAR PRESSURE; ISCHEMIA; LIFE EXPECTANCY; LIFESTYLE; LIVER TOXICITY; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; NAUSEA; NERVOUSNESS; OSTEOPOROSIS; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SKIN DISEASE; SMOKING CESSATION; STOMACH ULCER; STOMATITIS; SYMPTOMATOLOGY; TEMPORAL ARTERITIS; TREATMENT INDICATION; ULTRASOUND;

EID: 33645572179     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-006-0007-9     Document Type: Review

References (27)

1. Smetana GW, Shmerling RH: Does this patient have temporal arteritis? JAMA 2002, 287:92-101.
2. Schmidt WA, Gromnica-Ihle E: What is the best approach to diagnose large-vessel vasculitis? Best Pract Res Clin Rheumatol 2005, 19:223-242.
3. Danesh-Meyer H, Savino PJ, Gamble GG: Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 2005, 112:1098-1103.
4. Nuenninghoff DM, Hunder GG, Christianson TJ, et al.: Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003, 48:3522-3531.
5. Hunder GG: Treatment of giant cell (temporal) arteritis. In UpToDate. Edited by Rose BD. Waltham, MA: 2005. http://www.uptodate.com.
6. Zehr KJ, Mathur A, Orszulak TA, et al.: Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg 2005, 19:1512-1517.
7. Taylor-Gjevre R, Vo M, Shukla D, Resch L: Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005, 32:1186-1188.
8. Schmidt WA, Gromnica-Ihle E: Incidence of temporal arteritis in patients with polymyagia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology 2002, 41:46-52.
9. Schmidt WA, Kraft HE, Vorpahl K, et al.: Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
10. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP: Test performance of ultrasonography for giant cell arteritis. Ann Intern Med 2005, 142:359-369.
11. Schmidt WA, Gromnica-Ihle E: Duplex ultrasonography in temporal arteritis. Ann Intern Med 2003, 138:609; author reply 609-610.
12. Bley TA, Wieben O, Uhl M, et al.: High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 2005, 184:283-287.
13. Schmidt WA, Natusch A, Möller DE, et al.: Involvement of peripheral arteries in active giant cell arteritis: a study using color Doppler sonography. Clin Exp Rheumatol 2002, 20:309-318.
14. Schmidt WA, Blockmans D: Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005, 17:9-15.
15. Meller J, Strutz F, Siefker U, et al.: Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003, 30:730-736.
16. Younge BR, Cook BE Jr, Bartley B, et al.: Initiation of glucocorticoid therapy: before and after temporal artery biopsy. Mayo Clin Proc 2004, 79:483-491.
17. Chan CC, Paine M, O'Day J: Steroid management in giant cell arteritis. Br J Ophthalmol 2001, 85:1061-1064.
18. Foroozan R, Deramo VA, Buono LM, et al.: Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology 2003, 110:539-542.
19. Jover JA, Hernandez-Garcia C, Morado IC, et al.: Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 134:106-114.
20. Spiera RF, Mitnick HJ, Kupersmith M, et al.: A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001, 19:495-501.
21. Hoffman GS, Cid MC, Hellmann DB, et al.: A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002, 46:1309-1318.
22. Hoffman GS, Cid MC, Weyand CM, et al.: Phase II study of the safety and efficacy of infliximab in giant cell arteritis (GCA): 22 week interim analysis. Arthritis Rheum 2005, 52(suppl):S271.
23. Salvarani C, Manzini C, Paolazzi G, et al.: Infliximab in the treatment of polymyalgia rheumatica: a double-blind, randomized, placebo-controlled study. Arthritis Rheum 2005, 52(suppl):S676-S677.
24. Bhatia A, Ell PJ, Edwards JC: Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis. Ann Rheum Dis 2005, 64:1099-1100.
25. Nesher G, Berkun Y, Mates M, et al.: Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004, 50:1332-1337.
26. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis [no authors listed]. Arthritis Rheum 2001, 44:1496-1503.
27. Ray JG, Mamdani MM, Geerts WH: Giant cell arteritis and cardiovascular disease in older adults. Heart 2005, 91:324-328.